Cellectis SA (STU:ZVA)
€ 2.396 -0.068 (-2.76%) Market Cap: 248.52 Mil Enterprise Value: 162.47 Mil PE Ratio: 0 PB Ratio: 4.79 GF Score: 61/100

Cellectis SA at Barclays Virtual Gene Editing & Gene Therapy Summit - Presentation Transcript

Nov 16, 2020 / 02:15PM GMT
Release Date Price: €16.5 (+6.31%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Thank you, everyone. Welcome to our next speakers from Cellectis. Today with me, we have André Choulika, the Chief Executive Officer; Carrie Brownstein, Chief Medical Officer; and also Simon Harnest, SVP of Corporate Strategy and Finance.

With that, I hand over to André.

AndrÃ;Choulika
Cellectis S.A. - Co-Founder, CEO & Director

© -

Well, thank you very much, Gena. I think that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot